Serial 97037525
Dead / Abandoned — Abandoned — no statement of use filed (as of 18 Dec 2023)
What this means for you
This application is over — abandoned 18 Dec 2023. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 97037525
- Mark type
- Design / logo
- Filed
- 21 Sept 2021
- Published for opposition
- 15 Mar 2022
- Abandoned
- 18 Dec 2023
- Attorney of record
- Monica Riva Talley
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceuticals for reducing side effects or improving efficacy for cancer and oncology patients; pharmaceuticals for the prevention, treatment or management of superoxide mediated conditions; biotechnological preparations for medical use for the treatment of oncological disorders and treatment-related side effects
- Class 042 — Scientific and technological services: Research and development in the pharmaceutical and biotechnology fields
Owner
- Galera Therapeutics, Inc., Malvern, PA, US
- Galera Therapeutics, Inc., Malvern, PA, US
Prosecution history
- 18 Dec 2023 — ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
- 18 Dec 2023 — ABANDONMENT - NO USE STATEMENT FILED
- 09 May 2023 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 05 May 2023 — SOU EXTENSION 2 GRANTED
- 05 May 2023 — SOU EXTENSION 2 FILED
- 05 May 2023 — SOU TEAS EXTENSION RECEIVED
- 20 Oct 2022 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 18 Oct 2022 — SOU EXTENSION 1 GRANTED
- 18 Oct 2022 — SOU EXTENSION 1 FILED
- 18 Oct 2022 — SOU TEAS EXTENSION RECEIVED
- 10 May 2022 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 15 Mar 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Mar 2022 — PUBLISHED FOR OPPOSITION
- 23 Feb 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 08 Feb 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER